Novel Coronavirus (SARS-CoV-2/COVID-19)
Merck announced its submission for a Food and Drug Administration emergency use authorization of its investigational oral antiviral COVID-19 medicine.
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued details on several key changes related to the REGEN-COV COVID-19 monoclonal antibody therapy.
Experts break down what to expect, misconceptions and protective measures to take.
Hospitals and health systems are paying $24 billion more per year for clinical labor than they did before the COVID-19 pandemic, according to an analysis released by Premier.
The Centers for Medicare & Medicaid Services has modified its COVID-19 blanket waiver for Medicare-dependent hospitals (MDHs) to include hospitals that became newly classified as MDHs during the COVID-19 public health emergency.
The AHA released a new issue of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The frequency of anxiety and depression symptoms among U.S. adults increased after August 2020 and peaked during December 2020 and January 2021, mirroring the national weekly number of new COVID-19 cases, according to a study released by the Centers for Disease Control and Prevention.
AHA Board Chair Rod Hochman, M.D., is joined by Fritz Francois, M.D., chief medical officer at New York University Langone Health.
AstraZeneca said it has requested an emergency use authorization from the Food and Drug Administration for its long-acting antibody combination for the prevention of symptomatic COVID-19.
COVID-19 vaccinations may have helped prevent an estimated 265,000 COVID-19 infections, 107,000 hospitalizations and 39,000 deaths among Medicare beneficiaries between January and May 2021, according to a study released by the Department of Health and Human Services’ Office of the Assistant…